These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6240283)

  • 1. [Antifibrinolytic effect of heparin].
    Rozenfel'd MA; Leonova VB; Khavkina LS; Meshkov BB
    Biokhimiia; 1984 Oct; 49(10):1672-8. PubMed ID: 6240283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
    Alkjaersig N; Davies A; Fletcher A
    Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a serine protease with fibrinolytic activity from the dung beetles, Catharsius molossus.
    Ahn MY; Hahn BS; Ryu KS; Kim JW; Kim I; Kim YS
    Thromb Res; 2003; 112(5-6):339-47. PubMed ID: 15041280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophoretic demonstration of high molecular weight fibrin degradation products persisting in chronic subdural hematomas.
    Toyosawa M; Kashiwagi S; Pei W; Fujisawa H; Ito H; Nakamura K
    Electrophoresis; 1997 Jan; 18(1):118-21. PubMed ID: 9059832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of low-molecular peptides on the transformation of fibrinogen into fibrin].
    Levitskaia NG; Kleĭmenov AN; Petrosian MT; Rozenfel'd MA; Kalikhevich VN
    Biull Eksp Biol Med; 1987 Aug; 104(8):190-2. PubMed ID: 3620679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophoretic fractions and NH2-terminal amino acids of high-molecular tryptic fragments of fibrinogen and fibrin].
    Lugovskoĭ EV; Pozdniakova TM; Varetskaia TV; Derzskaia SG; Tolstykh VM
    Ukr Biokhim Zh; 1976; 48(6):743-9. PubMed ID: 1014141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinogen fragment D - inhibitor of fibrinolytic processes].
    Rozenfel'd MA; Fateeva LA; Gontar' ID
    Biokhimiia; 1983 Jul; 48(7):1135-40. PubMed ID: 6225469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM; Gamba C; Kordich LC
    Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin effect on hydrolysis of fibrin clots in a bull and a man with varying fibrinolytic systems].
    Makogonenko EM
    Ukr Biokhim Zh (1978); 1997; 69(5-6):109-16. PubMed ID: 9606832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of nonenzymatic fibrinolysis].
    Litvinov VI; Slabnov IuD; Zubairov DM
    Vopr Med Khim; 1981; 27(4):478-81. PubMed ID: 6457444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.
    Plow EF; Edgington TS
    J Clin Invest; 1975 Jul; 56(1):30-8. PubMed ID: 237938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple and practical method for isolation of an early plasmin degradation product of human fibrinogen.
    Takagi K; Kawai T
    Thromb Haemost; 1977 Jun; 37(3):464-70. PubMed ID: 142313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolytic properties of a heparin-ocrase complex].
    Kudrjashov BA; Liapina LA; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(4):573-82. PubMed ID: 64397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of heparin on factor XIa and plasmin.
    Rosenberg RD
    Thromb Diath Haemorrh; 1975 Feb; 33(1):51-62. PubMed ID: 235160
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.